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Background: Acute myocardial infarction (AMI) type is an important distinction to be made in both clinical and
health care research context, as it determines the treatment of the patient as well as affecting outcomes. The aim
of the paper was to determine the feasibility of distinguishing AMI type, either ST elevation myocardial infarction
(STEMI) or non-ST elevation myocardial infarction (NSTEMI), using ICD10 codes.
Methods: We carried out a retrospective descriptive analysis of hospital administrative data on AMI emergency
patients in England, for financial years 2000/1 to 2009/10. We used the performance of an angioplasty procedure
on the same day and on the same or next day of hospital admission as a proxy for STEMI.
Results: Among the ICD10 AMI subcategories, there were inconsistent trends, with some of the codes exhibiting a
gradual decline (such as I21.0 Acute transmural myocardial infarction of anterior wall, I21.1 Acute transmural
myocardial infarction of inferior wall, I22.0 Subsequent myocardial infarction of anterior wall and I22.1 Subsequent
myocardial infarction of inferior wall) and other codes an increase (in particular I21.9 Acute myocardial infarction,
unspecified and I22.9 Subsequent myocardial infarction of unspecified site). With the exception of the codes I21.4
Acute subendocardial myocardial infarction, I21.9 Acute myocardial infarction, unspecified, I22.8 Subsequent
myocardial infarction of other sites and I22.9 Subsequent myocardial infarction of unspecified site, all the other AMI
subcategories appear to have undergone a significant increase in the number of angioplasty procedures performed
the same or the next day of hospital admission from around 2005/6. There appear to be difficulties in accurately
identifying the proportion of STEMI/NSTEMI by sole reliance on ICD10 codes.
Conclusions: We suggest as the best sets of codes to select STEMI cases I21.0 to I21.3, I22.0, I22.1 and I22.8;
however, without any further adaptations, ICD10 codes are insufficient to clearly distinguish acute myocardial
infarction type.
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It is widely accepted that it is important to distinguish
between acute myocardial infarction (AMI) type as it de-
termines the clinical treatment of the patient [1,2] and
affects outcomes [3]. The universal definition of myo-
cardial infarction states that the term should be used
‘whenever there is evidence of myocardial necrosis in a
clinical setting consistent with myocardial ischemia’ [1].* Correspondence: r.alexandrescu@imperial.ac.uk
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distribution, and reproduction in any mediumIn this context, the patients presenting with ischaemic
symptoms and persistent electrocardiographic (ECG)
ST-segment elevation are categorised as ST elevation
myocardial infarction (STEMI). Non-ST segment eleva-
tion myocardial infarction (NSTEMI) is based upon the
diagnosis of infarction without the ST-segment elevation
at the time of symptoms. Of note, whereas STEMI diag-
nosis relies on ECG, the diagnosis of NSTEMI is more
complex, and ultimately depends upon elevation of car-
diac markers documenting myocardial injury. It is esti-
mated the great majority of cases are NSTEMI, the ratio
of NSTEMI to STEMI being at least 2:1 [4].entral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Alexandrescu et al. BMC Health Services Research 2013, 13:468 Page 2 of 8
http://www.biomedcentral.com/1472-6963/13/468Management of STEMI patients includes angioplasty,
clot-busting medication and coronary artery bypass graft
surgery, with angioplasty performed under strict 90
minutes call-to-balloon time requirements being the first
choice for the treatment of these patients. The standard
treatment for NSTEMI patients is medical therapy with
antiplatelet and anticoagulant medications. However,
“early invasive” strategy, i.e., coronary angioplasty per-
formed within the first 96 hours of first admission to
hospital, can be part of the treatment for NSTEMI pa-
tients who have an intermediate or higher risk of adverse
cardiovascular events [2]. The most recent data in
England 2011/2012, suggest an increase over time
with rates up to 62% of STEMI patients receiving pri-
mary angioplasty within 120 minutes from calling;
only around 20% of NSTEMI patients are referred for
angiography (with follow-on angioplasty if indicated)
within 24 hours of admission [4].
Usually the AMI type, either STEMI or NSTEMI, is
assessed from clinical information from the medical re-
cords. However, most research studies rely on adminis-
trative databases that use International Classification of
Diseases (ICD) to select and categorise diagnoses. With
the exception of the United States, Portugal, Spain and
Italy, the only countries with modern health care sys-
tems using ICD Ninth Revision, (i.e., ICD9-Clinical Mo-
dification (ICD9-CM)), all the other countries use ICD
Tenth Revision (ICD10) for coding purposes [5,6]. Where-
as the ICD9-CM has separate codes for STEMI and
NSTEMI [7], the standard ICD10 classification lacks these
specific codes. Of note, a more detailed classification has
been released in 2012 (ICD-10 - Clinical Modification
(ICD-10-CM)) which explicitly discriminates STEMI/
NSTEMI [8]. However, ICD-10-CM is not currently in
use in all countries and retrospective studies that include
data prior to 2013 will still need to differentiate STEMI
and NSTEMI subtypes using the original ICD-10 coding
framework. Research in the UK has made use of a classifi-
cation that identifies STEMI-related hospitalisations as
patient records with an ICD-10 primary diagnosis code of
I21.0, I21.1, I21.2, I22.0, I22.1 or I22.8 with ‘no record of a
previous STEMI hospitalisation within the 28 days prior
to admission’ [9,10]. Other recent research, undertaken
within an international context, makes use of a slightly dif-
ferent classification for STEMI using ICD10 codes (i.e.,
I21.0 to I21.3) [11]. These are informal, arbitrary classifica-
tions without rigorous validation. The aim of the current
analysis was to determine the feasibility of distinguishing
AMI type using an empirical approach of categorising
4-digit ICD10 codes.
Methods
Data were from the Hospital Episodes Statistics (HES)
for the financial years from 2000/1 to 2009/10. HospitalEpisodes Statistics are administrative data containing in-
formation on all admissions to English National Health
Service hospitals [12]. Each record in the database repre-
sents a finished consultant episode, i.e., the continuous
period during which an inpatient is under care of the
same consultant. The datasets contain patient and cli-
nical information, the primary and secondary diagnosis
fields being coded using ICD10. To avoid multiple
counting, we linked episodes of care into admissions
(spells) and admissions were linked together if the pa-
tient was transferred to another hospital (super-spells).
Acute myocardial infarction was defined as admission to
hospital with AMI as primary diagnosis. The ICD-10
codes used to define AMI were I21-I22, assigned for
each spell based on the primary diagnosis in the first
episode of care or, if the primary diagnosis was a vague
symptom or sign, we used the second episode to derive
the diagnosis. All emergency admissions (2000/1 to
2009/10) in England for AMI patients have been ex-
tracted based on these criteria.
To determine the feasibility of distinguishing AMI
type (STEMI vs. NSTEMI) using ICD10 subcategories
codes, we present coronary angioplasty procedure use
stratified by AMI ICD10 subcategories, over the study
period (2000/1 to 2009/10). Data for angioplasty proce-
dures were selected based on codes K49, K50 and K75
from the Office of Population Censuses and Surveys
Classification of Surgical Operations and Procedures,
fourth revision (OPCS 4), occurring in any procedure
field in any episode. Furthermore, based on the number
of days between the date of angioplasty and the date of
hospital admission, we selected two groups of AMI pa-
tients: those undergoing coronary angioplasty on the
‘same day’ and on the ‘same or next day’ of hospital ad-
mission. These are procedures that are performed in
clinical emergency scenarios. The ‘same or next day’ data
has been used as a sensitivity analysis for the ‘same day’
data on angioplasty procedures. We hypothesised that
the great majority of these procedures will be found pre-
dominantly in STEMI patients.
The percentages of AMI cases undergoing coronary
angioplasty have been computed by dividing the number
of procedures performed during a given year by the total
number of AMI patients (overall or within each specific
subcategory code) for that year. Table 1 presents a de-
scription of the ICD10 AMI codes and the correspon-
ding OPCS 4 coronary angioplasty codes.
In addition, a comparison was performed between our
study population and the Myocardial Infarction National
Audit Project (MINAP) database, the largest clinical
observational dataset of patients from England and Wales
hospitalised with an acute coronary syndrome [13].
MINAP data cover all acute hospitals that admit coronary
syndrome patients and, for each patient, includes detailed
Table 1 ICD10 diagnosis codes for AMI and the OPCS 4
codes for coronary angioplasty
Code Description
ICD10
I21 Acute myocardial infarction
I21.0 Acute transmural myocardial infarction of anterior wall
I21.1 Acute transmural myocardial infarction of inferior wall
I21.2 Acute transmural myocardial infarction of other sites
I21.3 Acute transmural myocardial infarction of unspecified site
I21.4 Acute subendocardial myocardial infarction
I21.9 Acute myocardial infarction, unspecified
I22 Subsequent myocardial infarction
I22.0 Subsequent myocardial infarction of anterior wall
I22.1 Subsequent myocardial infarction of inferior wall
I22.8 Subsequent myocardial infarction of other sites
I22.9 Subsequent myocardial infarction of unspecified site
OPCS 4
K49 Transluminal balloon angioplasty of coronary artery
K50 Other therapeutic transluminal operations on coronary artery
K75 Percutaneous transluminal balloon angioplasty and insertion
of stent into coronary artery
OPCS 4 Office of Population Censuses and Surveys Classification of Surgical
Operations and Procedures, fourth revision.
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ment). Of note, some of the hospitals do not report all
their data due to lack of resources. As a result, in practice,
MINAP dataset comprises the great majority of STEMI
patients and only a part of NSTEMI patients. The data
availability has restricted the comparison of STEMI and
NSTEMI cases to aggregate figures covering England and
Wales and the time period 2003 to 2009. For the purpose
of this analysis, HES data, reported on standard financial
year basis, were allocated to calendar years. Data manipu-
lation and analysis were performed using SAS (v9.1).
Study approval: We have permission from the NIGB
under Section 251 of the NHS Act 2006 (formerly
Section 60 approval from the Patient Information Ad-
visory Group) to hold confidential data and analyse
them for research purposes. We have approval to use
the data for research and measuring quality of deli-
very of healthcare, from the South East Ethics Re-
search Committee.
Results
The study population consisted of 716317 AMI admis-
sions over 2000/1 to 2009/10, 599485 Acute myocardial
infarction I21 (83.7%) and 116832 Subsequent myocar-
dial infarction I22 (16.3%). The commonest I21 subcode
was I21.9 (site unspecified, 43.3%) whereas within I22
the corresponding code was I22.9 (61.4%).Figure 1A and 1B present trends over 2000/1 to
2009/10 in the number of AMI cases stratified by sub-
category codes. Within I21, the number of cases coded
within subcategories I21.0 to I21.2 gradually declined from
34320 in 2000/1 to 16793 in 2009/10. Much larger fluctu-
ations were exhibited by I21.4 and I21.9 cases, with an
overall tendency to increase. Within subsequent myocar-
dial infarction, I22, the number of I22.0 and I22.1 cases
gradually declined over time. By contrast, the number of
I22.8 and, in particular, I22.9 cases increased over the
same study period.
Over the study period there was an increase in the
percentage of AMI cases undergoing coronary angio-
plasty on the same day and on the same or next day of
hospital admission. In 2009/10, 14.4% and 18.2% of AMI
cases underwent coronary angioplasty on the same day
and on the same or next day (data not shown). Analysis
stratified by subcategories codes (Figure 2A and 2B)
shows that, apart from the codes I21.4, I21.9, I22.8 and
I22.9, all the other AMI subcategories appear to have
undergone a significant increase in the number of angio-
plasty procedures performed on the same day or on the
same or next day of hospital admission, in particular
starting with the second part of the study, up to values
of minimum 26% for same day angioplasty and 29% for
same or next day angioplasty (i.e., both I21.2 and I22.0).
Of note, the increase in AMI cases subcategory I22.8
was restricted to the last two-year study period.
A comparison of HES data with MINAP database
(Figure 3) shows similar patterns in the temporal changes
in the number of cases for NSTEMI, although the two sets
of figures differ by an almost constant amount of cases.
The temporal pattern of STEMI cases is different be-
tween HES (decreasing) and MINAP data that is ra-
ther stable. Of note, MINAP data cover both England
and Wales whereas our study population is restricted
to England alone.
Discussion
We undertook a descriptive analysis of the trends in
diagnosis codes and angioplasty procedure use of the
AMI cases stratified by ICD10 subcategory codes to de-
termine the feasibility of the ICD10 codes to distinguish
between STEMI and NSTEMI.
Among the ICD10 AMI subcategories, the trends were
complex. The analysis clearly shows a gradual decline of
AMI cases coded as I21.0 and I21.1 as well as I22.0 and
I22.1 and an increase in AMI cases coded I22.8 and
I22.9. Research undertaken in England (using the classi-
fication described by Pereira et al) as well as elsewhere
(data relying on ICD-9CM) [10,13-15] has shown a re-
duction of STEMI cases and an increase in NSTEMI
cases. Possible explanations for the increase in NSTEMI
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Figure 1 Trends in the number of inpatients stratified by AMI ICD10 codes, HES data, England 2000/1-2009/10. (A) Acute Myocardial
Infarction I21. (B) Subsequent Myocardial Infarction I22.
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sensitive) marker for diagnosing AMI since 2005 (i.e.,
when its use became universal in England and Wales)
[10,14-16]. The previous UK classification identified
STEMI-related hospitalisations as patient records with
an ICD-10 primary diagnosis code of I21.0, I21.1, I21.2,
I22.0, I22.1 or I22.8. Based on our analysis, these are in-
deed the codes showing some decrease in the number of
cases, whereas the remaining ones, possible NSTEMI
cases, showed an (expected) increase in data reporting. Al-
though the findings reflect what we would expect with re-
gard to STEMI/NSTEMI cases, from this part of the
analysis it is difficult to draw the conclusion that certain
ICD-10 diagnosis codes I21.0, I21.1, I21.2, I22.0, I22.1 or
I22.8 are STEMI cases.
We have used data on coronary angioplasty performed
same day as well as same or next day of hospital ad-
mission to capture a great majority of procedures that
are performed in clinical emergency scenarios. Assuming
accurate classification by AMI type, we hypothesised
that coronary angioplasty procedures performed within
the same day of hospital admission will be foundpredominantly in STEMI patients. The results show se-
veral AMI subcategories appear to have undergone a sig-
nificant increase in the number of angioplasty procedures
same day/same or next day of admission, either starting
with the second part of the study period (I21.0 to I21.3,
I22.0 and I22.1) or only over the last two study years
(I22.8). Apart from I21.3, all these previously mentioned
ICD10 codes have been previously categorised as STEMI
patients, a classification that seems to be in agreement
with the results of the present analysis. However, the re-
sults also clearly suggest I21.3 falling into the STEMI cat-
egory. Of note, I21.3 has been included in the category
STEMI within some other international research [11]. The
MINAP 2010 report gives approximately 45% of STEMI
patients receiving primary angioplasty in England and
Wales over 2009/2010 [10]. The corresponding figures in
our study (using I21.0 to I21.2, I22.0, I22.1, and I22.8 data
over 2009) were 35.7% (same day angioplasty) and 41.3%
(same or next day angioplasty). Interestingly, I21.9, repre-
senting the great majority of I21 cases, exhibited only
moderate values of angioplasty use (under 10%). A further
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%
Year
I21.0 I21.1 I21.2 I21.3 I21.4
I21.9 I22.0 I22.1 I22.8 I22.9
Figure 2 Use of angioplasty (% out of total cases) stratified by AMI ICD10 codes, HES data, England 2000/1-2009/10. (A) Angioplasty
performed same day of hospital admission. (B) Angioplasty performed same or next day of hospital admission.
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pared with the rest of the AMI cases, these patients
tend to be older (age mean (SD), years 70.1 (13.5)
and 73.1 (11.5) vs. 66.1 (13.6), p < 0.0001) and have
more comorbidity conditions (Charlson index score mean
(SD), 0.96 (1.0) and 1.5 (0.9) vs. 0.81 (0.9), p < 0.0001), data


















Figure 3 Comparison of HES data with MINAP data stratified by
AMI type, 2000-2009.patients tend to be older and have higher comorbidity
scores [3], a finding that further supports our assumption
related to the I21.9 and I22.9 codes. However, we have
also found a fewer proportion of I21.9 and I22.9 patients
have been treated in a cardiology ward compared with the
rest of the AMI patients that might suggest poor diagnosis
or can explain the lower rates of angioplasty performed
within these two categories of patients (cardiology ward
of treatment 15.3% and 15.7% vs. 25.8%, p < 0.000), data
not shown.
The analysis leads to the conclusion that it is indeed
difficult to distinguish AMI type using the terminology
included in standard ICD10 without any other further
adaptations. However, we suggest as the best sets of
codes to select STEMI cases I21.0 to I21.3, I22.0, I22.1
and I22.8. Table 2 presents the ICD9 CM and ICD10
CM including the new versions that differentiate STEMI/
NSTEMI and the ICD10 classification with our pro-
posed description. It is noteworthy, within the new
version of ICD10 that comes into effect in October 2013
(ICD10-CM) STEMI and NSTEMI are mutually exclusive
based on the coding subcategories [8]. ICDS-10-CM
is the coding system developed in the United States,
Table 2 Relevant ICD 9 and ICD10 diagnosis codes for AMI
ICD
ICD9 ICD10 ICD10-CM
Code Previous description New description (October 2005) Code Current description Proposed description Code Description
410.01 Anterolateral wall STEMI of anterolateral wall I21 Acute myocardial infarction I21 ST elevation (STEMI) and non-ST elevation
(NSTEMI) myocardial infarction
410.11 Other anterior wall STEMI of other anterior wall I21.0 Acute transmural myocardial
infarction of anterior wall
STEMI I21.0 ST elevation (STEMI) myocardial infarction
of anterior wall
410.21 Inferolateral wall STEMI of inferolateral wall I21.1 Acute transmural myocardial
infarction of inferior wall
STEMI I21.1 ST elevation (STEMI) myocardial infarction
of inferior wall
410.31 Inferoposterior wall STEMI of inferoposterior wall I21.2 Acute transmural myocardial
infarction of other sites
STEMI I21.2 ST elevation (STEMI) myocardial infarction
of other sites
410.41 Other inferior wall STEMI of other inferior wall I21.3 Acute transmural myocardial
infarction of unspecified site
STEMI I21.3 ST elevation (STEMI) myocardial infarction
of unspecified site
410.51 Other lateral wall STEMI of other lateral wall I21.4 Acute subendocardial myocardial
infarction
NSTEMI I21.4 Non-ST elevation (NSTEMI) myocardial
infarction
410.61 True posterior wall STEMI of true posterior wall I21.9 Acute myocardial infarction, unspecified NSTEMI --- -----------------------------------------------------
410.71 Subendocardial NSTEMI I22 Subsequent myocardial infarction I22 Subsequent ST elevation (STEMI) and non-ST
elevation (NSTEMI) myocardial infarction
410.81 Other specified sites STEMI of other specified sites I22.0 Subsequent myocardial infarction
of anterior wall
STEMI I22.0 Subsequent ST elevation (STEMI) myocardial
infarction of anterior wall
410.91 Unspecified site Myocardial infarction NOS I22.1 Subsequent myocardial infarction
of inferior wall
STEMI I22.1 Subsequent ST elevation (STEMI) myocardial
infarction of inferior wall
--- ------------------------------- --------- I22.2 Subsequent non-ST elevation (NSTEMI)
myocardial infarction
I22.8 Subsequent myocardial infarction
of other sites
STEMI I22.8 Subsequent ST elevation (STEMI) myocardial
infarction of other sites
I22.9 Subsequent myocardial infarction of
unspecified site
NSTEMI I22.9 Subsequent ST elevation (STEMI) myocardial
infarction of unspecified site
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the UK, it will be implemented some time soon. The
transition to a new ICD coding system might be seen
more of a future, long term solution to the problem
of identifying STEMI and NSTEMI, rather than an
immediate one.
We acknowledge that is difficult to compare HES data
with MINAP records, except in aggregate [13]. Interes-
tingly, the number of STEMI cases seems to be lower
compared with MINAP STEMI data for most of the
study period. One possible explanation might relate to
the data coverage. Nevertheless, since Wales’s data might
account for up to 10% of AMI records, it is unlikely that
this would explain the entire differences in our compari-
son [17]. Perhaps an appropriate segregation of ‘real’
STEMI from NSTEMI cases within the large AMI sub-
category I21.9 (currently coded as NSTEMI) would make
some contribution in reducing the differences between
MINAP and our study population. However, in the ab-
sence of the clinical data this is less likely to be achievable.
With regard to the number of NSTEMI cases, this seems
to be higher compared with MINAP NSTEMI data. This
is unsurprising, considering that MINAP will not record
all patients having NSTEMI.
We used hospital administrative data that is limited by
the potential of misclassification bias in assigning pa-
tients to AMI subcategories as well as in relation o how
diagnoses are recorded by different hospitals. Moreover,
the lack of a gold standard with individual level data pre-
vented a true validation of the ICD-10 codes to differen-
tiate STEMI from NSTEMI. In this context it worth
noting research shows that even when specific codes to
differentiate STEMI from NSTEMI exists, i.e., ICD9-CM,
the correlation between ECG diagnoses and ICD-9 codes
is high, but there is still room for improvement [18]. The
disagreement has been attributed to a combination of fac-
tors including the training of coding staff, the information
available on medical records, the ambiguity of some AMI
cases or even the accuracy of the coding classification it-
self, suggesting the need for collective efforts from a wide
range of health care professionals in providing accurate
information.
Within countries that use ICD10 (or country-specific
versions of this classification), different approaches have
been implemented to distinguish between STEMI and
NSTEMI. In Scotland, coding guidelines have been re-
cently updated by adding a 5th digit for use only with
AMI codes, while in Canada, as an interim solution,
ICD10-CA has expanded a separate subcategory to cap-
ture relevant information in this regard [19,20]. Never-
theless, in Wales for example, no changes to the ICD10
codes have been made and, as a consequence, AMI
type is assessed based on further clarification from
the clinician [21].Conclusions
Our research suggests that there are difficulties in iden-
tifying accurate data on the proportion of STEMI/
NSTEMI by sole reliance on ICD10 codes. However,
we suggest the best sets of codes to select STEMI cases
are I21.0 to I21.3, I22.0, I22.1 or I22.8.
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